FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / deficiency-notice-penterra-to-veridian.docx
deficiency-notice-penterra-to-veridian.docx · 1018-00008

Parties

HARKNESS LLP
Cole LLP
Penterra Pharmaceuticals Corp
Broadleaf Scientific Consulting LLC
M. Burgess

Dates

September 6, 2024
June 10, 2024
August 14, 2024
August 16, 2024
August 19, 2024
August 22, 2024
August 28, 2024
December 31, 2023
June 30, 2024
September 20, 2024

Amounts

$900,000,000
$500,000,000
$2.1

Obligations

Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Agreement
Nothing in this letter shall be construed as a waiver, release, or modification of any of Buyer's rights or remedies under the Agreement, at law, or in equity
No delay or failure by Penterra in exercising any right or remedy under the Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or remedy preclude any other or further exercise thereof or the exercise of any other right or remedy